1. Canada Stocks

  2. •

    Health technology

  3. •

    Medical specialties
MEDICAL INTERNATIONAL TECHNOLOGY

MEDICAL INTERNATIONAL TECHNOLOGY

OOTC:MDLH
0.00
USD
0.00
(0.00%)
0.00EPS
261,344.34Market Cap
2003 Y
2004 Y
2005 Y
2006 Y
2007 Y
2008 Y
2009 Y
2010 Y
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
TTM
Revenue per Share
0.18
0.06
0.08
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
- -
Basic EPS, GAAP
-0.88
-0.4
-0.16
-0.14
-0.03
-0.09
-0.04
-0.01
-0.01
- -
0.01
- -
- -
- -
Free Cash Flow per Basic Share
-0.19
-0.09
-0.03
-0.11
-0.01
0.02
- -
- -
-0.01
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.03
- -
-0.06
-0.03
- -
-0.09
-0.07
-0.01
-0.01
-0.01
- -
- -
- -
- -
Tangible Book Value per Share
-0.03
- -
-0.06
-0.03
- -
-0.09
-0.07
-0.01
-0.01
-0.01
- -
- -
- -
- -
Basic Weighted Avg Shares
2
4
5
11
27
27
58
62
70
84
84
84
84
84
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
1
1
- -
1
1
- -
1
- -
Operating Margin (%)
-471.74
-70.24
-193.83
-546.9
-220.96
-718.23
-355.13
-153.42
-106.46
2.74
8.21
-16.04
-7.83
-99.49
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-2
-1
-1
-2
-1
-2
-2
-1
-1
- -
1
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-489.38
-721.19
-207.28
-558.19
-265.38
-718.52
-355.57
-147.02
-147.11
-11.04
116.06
-18.79
-11.21
-103
Working Capital
-1
- -
-1
- -
- -
-3
-5
-1
-1
-1
- -
- -
- -
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
-1
- -
- -
-3
-4
-1
-1
-1
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-28.54
-25.29
- -

Capital Structure

USD

•

in mil. unless spec.
Dec'16
Mar'16
Jun'16
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
84
84
84
Market Capitalization
1
1
- -

Working Capital

USD

•

in mil. unless spec.
Dec'16
Mar'16
Jun'16
Total Current Assets
- -
1
1
Cash, Cash Equivalents & STI
- -
1
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
1
1
Payables & Accruals
- -
1
1
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-8,770.24%
-38.26%
-23.97%
Free Cash Flow
11.52%
-24.57%
-22.76%
Net Income, GAAP
-106.35%
-244.49%
-23.61%
Sales/Revenue/Turnover
15.28%
15.34%
28.05%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2014
- -
- -
- -
- -
- -
2015
- -
- -
- -
- -
1
2016
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2014
- -
- -
- -
- -
- -
2015
- -
- -
- -
- -
- -
2016
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2014
- -
- -
- -
- -
- -
2015
- -
- -
- -
- -
- -
2016
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Karim Menassa
Sector
Health technology
Industry
Medical specialties
Address
Montréal Canada
IPO Date
Oct 10, 2003
Website
mitcanada.ca
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
Medical International Technology, Inc. is a medical device and life sciences company specializing in the design, development, manufacture, and commercialization of needle-free jet injection systems for human and animal healthcare applications. The company operates primarily through two business segments: Human Health and Animal Health. Its proprietary product portfolio includes the Med-Jet family of needle-free injectors for human medical and cosmetic applications, such as the Med-Jet H4 and Med-Jet MB systems utilized in the intradermal, subcutaneous, and intramuscular administration of vaccines, local anesthetics, insulin, hormones, and biopharmaceuticals; specialized aesthetic and dermatological delivery devices designed for precise meso-therapy and dermal administration; the Agro-Jet and Zoo-Jet series of heavy-duty, multi-dose needleless injectors engineered for mass livestock vaccination, veterinary medicine, and agricultural herd health management across swine, bovine, ovine, and poultry sectors; custom-engineered delivery nozzles, pneumatic power units, and portable propulsion packs; and an extensive range of single-use disposable consumables, including sterile ampoules, multi-dose vial adapters, filling accessories, and protective nozzle caps. Medical International Technology also provides technical support, system maintenance, training services, and custom development capabilities for institutional healthcare providers, veterinary clinics, commercial farming enterprises, and government health agencies across North America, Europe, Asia-Pacific, Latin America, and the Middle East. In recent operational developments, the company has focused on expanding its international commercial footprint through new regional distribution agreements and strategic alliances across veterinary and agricultural markets; scaling the adoption of its Agro-Jet platform to address biosecurity concerns and reduce cross-contamination in livestock production; advancing development on next-generation pneumatic and microprocessor-controlled micro-injection systems for targeted therapeutic delivery; optimizing its manufacturing infrastructure to increase production volumes for single-use consumable components; and advancing regulatory compliance and quality assurance initiatives under ISO 13485 standards to facilitate market access across international jurisdictions. Founded in 1999, Medical International Technology, Inc. is headquartered in Montreal, Quebec, Canada.